As healthcare professionals, we are witnessing an alarming increase in obesity rates worldwide. This rise is accompanied by a surge in associated comorbidities like type 2 diabetes, cardiovascular diseases, and certain types of cancer. Hence, it is crucial to explore effective strategies for managing obesity.
Behavioral interventions form the cornerstone of obesity management. They involve dietary modifications, physical activity enhancement, and behavioral changes. These interventions can be delivered individually or in groups, face-to-face or remotely. The key is to customize the approach based on patient's needs and preferences.
Pharmacotherapy can be considered in patients with a BMI ≥30 or ≥27 with comorbidities, who have not responded to behavioral interventions. The choice of drug should be guided by the patient's comorbid conditions, potential side effects, and cost. Regular follow-up is essential to monitor efficacy and adverse effects.
Endoscopic and surgical interventions are reserved for patients with severe obesity (BMI ≥40 or ≥35 with comorbidities) who have not responded to non-surgical strategies. While these methods have shown significant weight loss and improvement in comorbid conditions, they are associated with potential complications and require lifelong medical follow-up.
Managing obesity requires an interdisciplinary approach involving dietitians, exercise physiologists, behavioral therapists, pharmacists, and surgeons. This team-based approach ensures comprehensive care, addressing all aspects of obesity.
Obesity management is a complex, multifaceted process requiring a personalized, patient-centered approach. It involves behavioral interventions, pharmacotherapy, endoscopic or surgical interventions, and an interdisciplinary team approach. As healthcare professionals, we need to stay updated with the latest evidence-based strategies to provide optimal care to our patients with obesity.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation